Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRent ExpenseResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShare-based Compensation (IS)Share-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Avricore Health (AVCRF) Income towards Parent Company (2016 - 2025)

Avricore Health has reported Income towards Parent Company over the past 12 years, most recently at -$321177.9 for Q4 2025.

  • Quarterly Income towards Parent Company rose 76.07% to -$321177.9 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$444938.7 through Dec 2025, up 66.85% year-over-year, with the annual reading at -$981497.4 for FY2025, 26.92% up from the prior year.
  • Income towards Parent Company was -$321177.9 for Q4 2025 at Avricore Health, up from -$1.2 million in the prior quarter.
  • Over five years, Income towards Parent Company peaked at -$7592.1 in Q1 2021 and troughed at -$2.0 million in Q3 2024.
  • The 5-year median for Income towards Parent Company is -$1.5 million (2022), against an average of -$1.3 million.
  • Year-over-year, Income towards Parent Company crashed 23215.81% in 2022 and then soared 76.07% in 2025.
  • A 5-year view of Income towards Parent Company shows it stood at -$1.8 million in 2021, then grew by 8.65% to -$1.6 million in 2022, then increased by 12.12% to -$1.4 million in 2023, then increased by 5.77% to -$1.3 million in 2024, then soared by 76.07% to -$321177.9 in 2025.
  • Per Business Quant, the three most recent readings for AVCRF's Income towards Parent Company are -$321177.9 (Q4 2025), -$1.2 million (Q3 2025), and -$1.5 million (Q2 2025).